ATTEST™ is developing the next generation of metabolite biomarker test technology. Current metabolite testing is invasive and based on analyte-specific disposable reagents. Our non-invasive solution, based on magnetic resonance spectroscopy (MRS), eliminates metabolite specific reagents and can quantitate many metabolite biomarkers important in clinical medicine, improving patient outcomes and provider workflows, while lowering recurring costs.